The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Sympathetic Neural Activation in Visceral Obesity
Abstract
Background— Muscle sympathetic nerve activity (MSNA) is elevated in obese humans. However, the potential role of abdominal visceral fat as an important adipose tissue depot linking obesity to elevated MSNA has not been explored. Accordingly, we tested the hypothesis that MSNA would be increased in men (age=18 to 40 years, body mass index ≤35 kg/m 2 ) with higher abdominal visceral fat (HAVF; n=13, abdominal visceral fat=118.1±15.8 cm 2 ) compared with their age- (28.7±2.4 versus 25.5±2.0 years, P >0.05), total fat mass-matched (20.6±2.1 versus 20.8±2.4 kg, P >0.05) and abdominal subcutaneous fat-matched (230.6±24.9 versus 261.4±34.8 cm 2 , P >0.05) peers with lower abdominal visceral fat levels (LAVF; n=13, visceral fat= 73.0±6.0 cm 2 ). Methods and Results— MSNA (microneurography), body composition (dual energy x-ray absorptiometry), and abdominal visceral and subcutaneous fat (computed tomography) were measured in 37 sedentary men across a wide range of adiposity. MSNA was ≈55% higher in men with HAVF compared with men with LAVF (33±4 versus 21±2 bursts/min, P <0.05). Furthermore, MSNA was more closely associated with the level of abdominal visceral fat ( r =0.65, P <0.05) than total fat mass ( r =0.323, P <0.05) or abdominal subcutaneous fat ( r =0.27, P =0.05). The relation between MSNA and abdominal visceral fat was independent of total body fat ( r =0.61, P <0.05). Conclusions— The results of our study indicate that MSNA is elevated in men with visceral obesity. Our observations are consistent with the idea that abdominal visceral fat is an important adipose tissue depot linking obesity with sympathetic neural activation in humans. Furthermore, these findings may have important implications for understanding the increased risk of developing cardiovascular diseases in individuals with visceral obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sympathetic activation has already been associated with many of the individual components of the MS, such as visceral obesity, 5 insulinemia, 6 EHT, [1][2][3][4] and type 2 diabetes.7”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [5]
In the citing paper
“First, MS components such as visceral obesity, peripheral insulin resistance, and reactive hyperinsulinemia have been found to result in sympathetic hyperactivity.[5][6][7]”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [5]
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
Treatment of obesity: need to focus on high risk abdominally obese patients
Després, J., Lemieux, I., & Prud'homme, D. (2001) · BMJ · doi:10.1136/bmj.322.7288.716 · Cited by 831
Sympathetic Activation in Obese Normotensive Subjects
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., Giannattasio, C., Brunani, A., Cavagnini, F., & Mancia, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.560 · Cited by 614
Sympathetic Activity in Obese Subjects With and Without Obstructive Sleep Apnea
Narkiewicz, K., van de Borne, P. J. H., Cooley, R. L., Dyken, M. E., & Somers, V. K. (1998) · Circulation · doi:10.1161/01.cir.98.8.772 · Cited by 525
Eckel, R. H. (1997) · Circulation · doi:10.1161/01.cir.96.9.3248 · Cited by 512
Reaven, G. M. (2002) · Circulation · doi:10.1161/01.cir.0000019884.36724.d9 · Cited by 494
Body fat and sympathetic nerve activity in healthy subjects.
Scherrer, U., Randin, D., Tappy, L., Vollenweider, P., Jéquier, E., & Nicod, P. (1994) · Circulation · doi:10.1161/01.cir.89.6.2634 · Cited by 383
Grassi, G., Seravalle, G., Colombo, M., Bolla, G., Cattaneo, B. M., Cavagnini, F., & Mancia, G. (1998) · Circulation · doi:10.1161/01.cir.97.20.2037 · Cited by 364
Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain.
Spraul, M., Ravussin, E., Fontvieille, A. M., Rising, R., Larson, D. E., & Anderson, E. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116760 · Cited by 293
Research works printed but not linked: 10
Cited by
Sorted by citations
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Obesity-Associated Hypertension
Rahmouni, K., Correia, M., Haynes, W. G., & Mark, A. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000151325.83008.b4 · Cited by 788
Sympathetic Nervous System Overactivity and Its Role in the Development of Cardiovascular Disease
Malpas, S. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00007.2009 · Cited by 696
The Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
Obesity, Sleep Apnea, and Hypertension
Wolk, R., Shamsuzzaman, A. S. M., & Somers, V. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000101686.98973.a3 · Cited by 532
Metadata
- Authors
- Alvarez, G. E., Beske, S. D., Ballard, T. P., & Davy, K. P.
- Affiliations
- University of Mississippi Medical Center (US)
- ORCID
- Davy, Kevin P.
- Venue
- Circulation
- Published
- 2002-11-12
- Volume
- 106
- Issue
- 20
- Pages
- 2533-2536
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2138900790
- Cited by
- 557
- References
- 21
- Citations by year
- 2026: 3 · 2025: 16 · 2024: 19 · 2023: 13 · 2022: 16 · 2021: 18 · 2020: 21 · 2019: 22 · 2018: 18 · 2017: 19 · 2016: 29 · 2015: 27 · 2014: 42 · 2013: 24 · 2012: 29
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL62283, K02HL067227, R01HL062283, HL67227)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- visceral obesity, visceral fat, muscle sympathetic nerve activity, sympathetic activation, adipose tissue depots, subcutaneous adipose tissue, body composition, cardiovascular risk
- MeSH terms
- Adipose Tissue, Adolescent, Adult, Anthropometry, Body Composition, Humans, Male, Obesity, Sympathetic Nervous System, Baroreflex, Muscle, Skeletal, Abdominal Cavity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
